EC Ophthalmology

Research Article Volume 15 Issue 8 - 2024

Rationale for Neurotrophic Regulation in Conservative Treatment of Keratoconus

Evgeny S Milyudin1*, Kseniy E Kuchuk2 and Oksana Yu Smorodinova3

11"Samara State Medical University” of the Ministry of Healthcare of the Russian Federation, Samara, Russia
22Samara Regional Clinical Ophthalmological Hospital Named After T.I. Eroshevsky, Russia
33Center of Contact Correction "Doctor Lens", Russia

*Corresponding Author: Evgeny S Milyudin, “Samara State Medical University” of the Ministry of Healthcare of the Russian Federation, Samara, Russia.
Received: June 21, 2024; Published: July 31, 2024



Degradation of the corneal stroma is caused by an imbalance of a number of enzymes of the prooxidant and antioxidant systems. An imbalance in the enzymes of the prooxidant and antioxidant systems causes thinning of the stroma and the appearance of stromal scars.

The purpose of our study was to evaluate the neurotrophic regulation of metabolic processes in patients with early stage keratoconus and the possibility of correcting conservative treatment depending on the identified imbalance.

The study used the results of observation of patients with stages I - III of keratoconus (classification by M. Amsler (1961), J. Krumeich (1998). All patients with corneal and corneoscleral rigid gas permeable contact lenses of various models and manufacturers. Duration of observation from 2005 to 2019 year, along with the study of the ophthalmological status of the patients, before starting conservative treatment, cardiointervalography was performed to clarify the vegetative status.

In 97% of cases, autonomic dysfunction was determined in our patients, while in 85% of all those examined, a significant predominance of sympathicotonic neurotrophic regulatory processes was determined. Based on this, we have proposed an effect that allows, at the first stage, to enhance cholinergic neurotrophic regulatory influences and activating aerobic processes in the tissues of the eyeball. At the next stage of treatment for keratoconus, they provide membrane stabilizing (regulation of the synthesis of phospholipids and proteins, stabilization and normalization of the structure of cell membranes), antioxidant (inhibition of the formation of free radicals and lipid peroxidation of cell membranes), and antihypoxic effects.

Analysis of the results of long-term (more than a year) observation of patients with keratoconus receiving conservative treatment aimed at normalizing the neurotrophic effect on regenerative processes in the tissues of the eye showed the possibility of stabilizing the pathological process and revealed disease progression in only three patients from the group with stage II keratoconus, 4% of all patients). All other patients experienced long-term stabilization of the disease. Three patients who had progression of keratoconus from stage II to stage III underwent a corneal collagen cross-linking procedure.

 Keywords: Keratoconus; Monitoring; Autonomic Reactivity; Neurotrophic Regulation; Oxidative Stress; Conservative Treatment of Keratoconus

 

  1. Bikbov MM., et al. “Genetic aspects of keratoconus development”. Russian Journal of Genetics 5 (2017): 519-527.
  2. Hollingsworth JG., et al. “Correlation of the keratoconic cornea in vivo by confocal microscopy and in vitro by light microscopy”. Cornea4 (2005): 397‑405.
  3. Abahussin M., et al. “3D collagen orientation study of the human cornea using x-ray diffraction and femtosecond laser technology”. Investigative Ophthalmology and Visual Science11 (2009): 5159-5164.
  4. Gan L and Johnson JA. “Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases”. Biochimica et Biophysica Acta 8 (2014): 1208-1218.
  5. Kenney CM and Brown DJ. “The cascade hypothesis of keratoconus”. Contact Lens and Anterior Eye 3 (2003): 139-146.
  6. Smith TG., et al. “The human side of hypoxia-inducible factor”. British Journal of Haematology3 (2008): 325-334.
  7. Amsler M. “Quelles donnees du probleme du keratocone”. Bulletin de la Societe Belge d'Ophtalmologie 26 (1961): 331-354.
  8. Krumeich JH., et al. “Live-epikeratophakia for keratoconus”. Journal of Cataract and Refractive Surgery 4 (1998): 456-463.
  9. Baevsky PM., et al. “Mathematical analysis of heart rate measurements under stress”. M. Nauka (1984): 221.
  10. Baevsky PM and Ivanov GG. “Heart rate variability: theoretical aspects and clinical applications”. Ultrasound and Functional Diagnostics 3 (2001): 108-127.
  11. Egorova GB and Rogova A Ya. “Keratoconus. The methods and monitoring’s”. Vestnik Oftalmologii1 (2013): 61-66.
  12. Abugova TD. “Keratoconus: clinical lecture for doctors and optometrists”. Saint Peterborg: OOO RA “Eyelid” (2015): 94.
  13. Belokon NA and Kuberger MB. “Diseases of the heart and blood vessels in children: Hands for doctors”. M.: Medicine (1987).
  14. Skupchenko VV and Milyudin ES. “Phasotonic homeostasis and healing”. Monograph. Samara Samara State Medical University (1994).
  15. Kruk J., et al. “The role oxidative stress in the pathogenesis of eye diseases: current status and a dual role of physical activity”. Mini-Reviews in Medicinal Chemistry 3 (2015): 241-257.
  16. Kruk J and Duchnik E. “Oxidative stress and skin diseases: possible role of physical activity”. Asian Pacific Journal of Cancer Prevention 2 (2014): 561-568.
  17. Rabinowitz YS and Rasheed K. “KISA% index: a quantitative videokeratography algorithm embodying minimal topographic criteria for diagnosing keratoconus”. Journal of Cataract and Refractive Surgery 10 (1999): 1327-1335.
  18. Steinberg J., et al. “Correlation of the KISA% index and Scheimpflug tomography in 'normal', 'subclinical', 'keratoconus-suspect' and 'clinically manifest' keratoconus eyes”. Acta Ophthalmologica 3 (2015): e199-207.

Evgeny S Milyudin., et al. "Rationale for Neurotrophic Regulation in Conservative Treatment of Keratoconus." EC Ophthalmology 15.8 (2024): 01-07.